±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1442  |  »Ø¸´: 4
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð ÒÑÓÐ1È˲ÎÓë

FDAÖÐReference StandardºÍReference Listed Drug¸÷ÓÐÊ²Ã´Çø±ð£¿

Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð
U{@U@H2D62L5W}4VFGFMBJS.png
»Ø¸´´ËÂ¥
Ö»ÊDzÁÉË
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

5Â¥2017-02-04 16:42:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 5 ¸ö»Ø´ð

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÑîÎÄËÉ˧: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2017-02-04 16:18:29
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. To facilitate generic drug development, FDA generally selects a single reference  standard that ANDA applicants must use in any in vivo testing conducted to support a demonstration of bioequivalence. FDA selects a single reference standard to ensure the greatest  level of consistency between a generic drug and its RLD and among generic drugs. Ordinarily,  the reference standard selected by FDA will be the RLD. FDA usually selects as the reference standard the highest strength available for drug products with multiple approved strengths.

reference standardÓ¦¸ÃÊÇ×÷ΪBE±ØÐëÓõIJαÈÖÆ¼ÁµÄÒâ˼£¨Ò»°ãµÄreference standard¾ÍÊÇRLD£©

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2017-02-04 16:07:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
2Â¥: Originally posted by zhangxuan200 at 2017-02-04 16:07:55
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. T ...

лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿
Ö»ÊDzÁÉË
3Â¥2017-02-04 16:23:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
3Â¥: Originally posted by ÑîÎÄËÉ˧ at 2017-02-04 16:23:02
лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿...

¼ûÕâ¸öÖ¸µ¼Ô­Ôò£¬¸Õ³öµÄ¡°Referencing Approved Drug Products in ANDA Submissions.¡±
4Â¥2017-02-04 16:41:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¸÷λÀÏʦºÃ£¬ÎÒµÄһ־ԸΪ±±¾©¿Æ¼¼´óѧ085601²ÄÁÏר˶ +12 Koxui 2026-03-28 12/600 2026-03-31 23:17 by wwytracy
[¿¼ÑÐ] 070300»¯Ñ§×¨Òµ279µ÷¼Á +10 ¹þ¹þ¹þ^_^ 2026-03-31 10/500 2026-03-31 23:13 by liu823948201
[¿¼ÑÐ] 288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤ +18 ÂåÉñ¸ç¸ç 2026-03-31 18/900 2026-03-31 21:55 by haohaichenji
[¿¼ÑÐ] ²ÄÁÏר˶µ÷¼Á +13 Ò¬Ò¬¡£ 2026-03-29 13/650 2026-03-31 16:37 by hypershenger
[¿¼ÑÐ] 311Çóµ÷¼Á +9 À¶ÔÂÁÁÁÁ 2026-03-30 9/450 2026-03-31 16:32 by yedezhan
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á +13 ÉîVËÞÉá°É 2026-03-30 14/700 2026-03-31 16:28 by hypershenger
[¿¼ÑÐ] 354Çóµ÷¼Á +3 lxb598 2026-03-31 4/200 2026-03-31 13:42 by sophie2180
[¿¼ÑÐ] 0703»¯Ñ§ +20 ÄÝÄÝninicgb 2026-03-27 20/1000 2026-03-31 13:33 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 266·Ö£¬Çó²ÄÁÏÏà¹Ø×¨Òµµ÷¼Á +10 ÍÛºôºßºôºß 2026-03-30 12/600 2026-03-31 11:00 by ÐÜÒ»µ¶
[¿¼ÑÐ] 291Çóµ÷¼Á +12 Y-cap 2026-03-29 15/750 2026-03-31 09:25 by Huaxue_Wang
[¿¼ÑÐ] 297Çóµ÷¼Á +17 ÌïºéÓÐ 2026-03-26 18/900 2026-03-30 18:32 by nothingͶ¸åÖÐ
[¿¼ÑÐ] 279Çóµ÷¼Á +4 µûÎèÇáÈÆ 2026-03-29 4/200 2026-03-29 09:45 by laoshidan
[¿¼ÑÐ] 356Çóµ÷¼Á +3 gysy?s?a 2026-03-28 3/150 2026-03-29 00:33 by 544594351
[¿¼ÑÐ] 283Çóµ÷¼Á +3 A child 2026-03-28 3/150 2026-03-28 15:41 by ms629
[¿¼ÑÐ] 312£¬ÉúÎïѧÇóµ÷¼Á +3 СÒëͬѧabc 2026-03-28 3/150 2026-03-28 15:32 by ÂäÉ˼
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
[¿¼ÑÐ] 085405 ¿¼µÄ11408Çó¸÷λÀÏʦ´ø×ß +3 Qiuѧing 2026-03-28 3/150 2026-03-28 09:19 by ÀֺǺǵÄ×·ÃÎÈË
[¿¼ÑÐ] 308Çóµ÷¼Á +7 īīĮ 2026-03-27 7/350 2026-03-28 07:43 by ÈÈÇéɳĮ
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á£¬¸÷λÀÏʦ¿´¿´ÎÒ£¡£¡£¡ +5 Æîì÷ì÷ 2026-03-25 5/250 2026-03-27 21:44 by ¶«·½ÖíÖí
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-03-26 3/150 2026-03-26 19:57 by nihaoar
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û